Thus, the IFN-γ/JAK/STAT1/NK2R pathway is critical in inhibiting the advancement of liver cancer by enhancing the antitumor immune response through CD8+ T cell cytotoxicity. The gene discussed is STAT1; the disease is liver cancer.